Lilly Donohue
CIK: 0002023165
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Donohue Lilly
Donohue Lilly (SEC CIK 0002023165) files insider reports with the SEC as Director of SONIDA SENIOR LIVING, INC. (SNDA) and Director of NATIONAL HEALTH INVESTORS INC (NHI).
Signal8 holds 4 ownership filings by Donohue Lilly (1 Form 3, 3 Form 4), filed between Jun 12, 2025 and Jun 15, 2026. Those filings report 3 transactions, from Jun 10, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Donohue Lilly's filings is in DALLAS, TX.
Recent filings by Donohue Lilly
Other insiders filing for SONIDA SENIOR LIVING, INC. (SNDA)
- Simanovsky Michael, Director
- Harris Benjamin P, Director
- Nikodemus Anton D., Chief Operating Officer
- Mauldin Stephen H, Director
- KRUEGER JILL M, Director
- Martin J Chandler, Director